Community-acquired pneumonia: Difference between revisions
Line 34: | Line 34: | ||
==[[Community-acquired pneumonia risk factors|Risk Factors]]== | ==[[Community-acquired pneumonia risk factors|Risk Factors]]== | ||
==[[Community-acquired pneumonia | ==[[Community-acquired pneumonia screening|Screening]]== | ||
==[[Community-acquired pneumonia natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ==[[Community-acquired pneumonia natural history, complications and prognosis|Natural History, Complications and Prognosis]]== |
Latest revision as of 17:25, 30 November 2020
Resident Survival Guide |
Community-Acquired Pneumonia Microchapters |
Differentiating Community-acquired pneumonia from other Diseases |
Diagnosis |
Treatment |
Case Studies |
Community-acquired pneumonia On the Web |
American Roentgen Ray Society Images of Community-acquired pneumonia |
Directions to Hospitals Treating Community-acquired pneumonia |
Risk calculators and risk factors for Community-acquired pneumonia |
For the main page on pneumonia, click here.
For hospital-acquired pneumonia, click here.
For patient information on pneumonia, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]; Nazma Hanif, MD[3]
Assistant Editor-In-Chief: Simran Singh
Synonyms and keywords: CAP
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Community-acquired pneumonia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Severity Criteria | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | Ultrasound | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies